The U.S. Food and Drug Administration has approved Zepatier with or without ribavirin for the treatment of chronic Hepatitis C genotypes 1 and 4 infections in adult patients.
Tag Archive for: FDA
A network building capacity to prevent, manage and treat hepatitis B and C in NYC
